Sign in
AAVXF Stock Price, Chart, Stats & News
Abivax S.A.
Save
Abivax S.A. (AAVXF) does not currently pay a dividend.
10.21B
Market cap
–
Current P/E
0.94x
Forward P/E
AAVXF chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Abivax S. A., a French biopharmaceutical firm, specializes in the discovery and enhancement of pharmaceutical treatments targeting inflammatory conditions, infectious illnesses, and various forms of cancer. The company's flagship compound, ABX464, is currently undergoing Phase IIb clinical evaluations for ulcerative colitis, Crohn's disease, and COVID-19.
Similar securities
Based on sector and market capitalization
Report issue